Biotech

All Articles

Enanta's RSV antiviral crushes popular bunch in problem research

.Enanta Pharmaceuticals has actually linked its respiratory system syncytial infection (RSV) antivir...

Biogen containers SAGE-324 collaboration after important agitation stop working

.Biogen has administered the last ceremonies to its cooperation with Sage Therapeutics on SAGE-324, ...

AbbVie Parkinson's medicine from $8.7 B Cerevel purchase credit ratings

.On the very same day that some Parkinson's ailment medications are actually being questioned, AbbVi...

Arch closes $3B-plus fund to promote biopharma startups

.On the heels of a $3 billion fund from Bain Funds Life Sciences, Arch Project Allies is verifying i...

Orion to use Aitia's 'digital twins' to locate brand new cancer cells medications

.Finnish biotech Orion has actually snooped possible in Aitia's "electronic identical twin" speciali...

Windtree's surprise med raises high blood pressure in most current period 2 gain

.While Windtree Rehabs has battled to grow the economic roots needed to have to survive, a period 2 ...

2 cancer biotechs combine, making international impact

.OncoC4 is taking AcroImmune-- and also its internal clinical production capacities-- under its own ...

Amgen records very first phase 3 win for $400M eczema medication

.Amgen has shared (PDF) the first period 3 information on its $400 million chronic eczema medicine, ...

Biogen, UCB record phase 3 lupus win after neglecting earlier test

.Biogen as well as UCB's gamble on developing in to phase 3 on the back of a broken study looks to h...

Aptadir really hopes brand-new RNA inhibitors can easily reverse tricky cancers

.Italian biotech Aptadir Therapeutics has actually introduced with the pledge that its own pipe of p...